§483.10(g)(14) Notification of Changes. (i) A facility must immediately inform the resident; consult with the resident's physician; and notify, consistent with his or her authority, the resident representative(s) when there is- (A) An accident involving the resident which results in injury and has the potential for requiring physician intervention; (B) A significant change in the resident's physical, mental, or psychosocial status (that is, a deterioration in health, mental, or psychosocial status in either life-threatening conditions or clinical complications); (C) A need to alter treatment significantly (that is, a need to discontinue an existing form of treatment due to adverse consequences, or to commence a new form of treatment); or (D) A decision to transfer or discharge the resident from the facility as specified in §483.15(c)(1)(ii). (ii) When making notification under paragraph (g)(14)(i) of this section, the facility must ensure that all pertinent information specified in §483.15(c)(2) is available and provided upon request to the physician. (iii) The facility must also promptly notify the resident and the resident representative, if any, when there is- (A) A change in room or roommate assignment as specified in §483.10(e)(6); or (B) A change in resident rights under Federal or State law or regulations as specified in paragraph (e)(10) of this section. (iv) The facility must record and periodically update the address (mailing and email) and phone number of the resident representative(s).
§483.10(g)(15) Admission to a composite distinct part. A facility that is a composite distinct part (as defined in §483.5) must disclose in its admission agreement its physical configuration, including the various locations that comprise the composite distinct part, and must specify the policies that apply to room changes between its different locations under §483.15(c)(9).
|
Observations:
Based on review of clinical records, as well as staff interviews, it was determined that the facility failed to ensure that the physician was notified that a resident's medication was unavailable for one of 29 residents reviewed (Resident 11).
Findings include:
An admission Minimum Data Set (MDS) assessment for Resident 11, dated May 15, 2026, revealed that the resident was cognitively intact, required assistance from staff for daily care needs, had an indwelling urinary catheter (a tube inserted and held in the bladder to drain urine), and had diagnoses that included Benign Prostatic Hyperplasia (BPH- condition in which the prostate gland [a walnut-sized gland in the male reproductive system that sits directly below the bladder] grows larger than normal).
Physician's orders for Resident 11 dated August 6, 2026, included for the resident to receive 30 milliliters (ml) of Renacidin Irrigation Solution (medical irrigation solution used inside the lower urinary tract to dissolves specific types of bladder stones and prevent mineral buildup or clogs in indwelling urinary catheters) to irrigate his catheter every shift for sediment for seven days, clamping for 30-60 minutes.
Review of the Treatment Administration Record (TAR) for Resident 11 dated August 2026, revealed that from August 6 at 9:58 p.m. through August 9 at 10:00 p.m., for a total of 11 administrations, the medication/irrigation was not administered because the medication was not available from the pharmacy. There was no documented evidence that the physician was notified that the medication was unavailable and therefore not administered as ordered.
Interview with the Director of Nursing on August 13, 2026, at 10:02 a.m. confirmed that the physician was never notified that the above-mentioned medication for Resident 11 was not available from the pharmacy and therefore not administered on the dates identified and the physician should have been notified.
28 Pa. Code 211.12(d)(3)(5) Nursing Services.
| | Plan of Correction - To be completed: 09/14/2026
On August 13, 2026 a review of resident records indicated that Resident 11 did not receive Renacidin irrigation solution as ordered. The Renacidin was not delivered and unavailable from the pharmacy. Physician was then made aware and new orders were received for an alternative treatment. Education by the Director of Nursing/designee will be provided to licensed nursing staff to report medications or treatments which are not available. Registered Nurse is to notify physician of medication/treatments that are not available/missed. Documentation of physician notification and response is to be documented in the resident's chart The Director of Nursing or designee will complete a 7-day look back on orders received, checking that treatments and medications were given as ordered. If medication or treatment is not available or missed, documentation will be reviewed for physician notification and alternative orders. The Director of Nursing or designee will complete daily audits for 1 week on all new medication/treatment orders, 2 x weekly audits for 2 weeks, then weekly for 2 weeks on residents receiving new medication or treatment orders and if physician was notified if not given. All audits will be reviewed by Interdisciplinary Team during monthly Quality Assurance meetings.
|
|